Related Experiment Videos
[Genetic diagnosis for drug resistance in cancers]
T Funato1, S Fujimaki, J Fujiwara
1Department of Molecular Diagnostics, Tohoku University, School of Medicine, Sendai.
Abstract:
The failure of chemotherapy to eradicate tumor cells is often due to the development of drug resistance. MDR(multidrug resistance) whose one form of resistance results from a decreased intracellular accumulation of the drugs, most often mediated by the overexpression of P-glycoprotein. MRP also related to pump function of cell membrane in acute leukemia. We have developed the new quantitative assay based on real-time PCR to measure expression of drug-resistance related genes such as MDR-1 and MRP in clinical samples. These results indicates that real-time PCR system is a reliable method to quantitatively determine drug resistant genes expression, it may be to predict responsiveness to chemotherapy by using this technique.
Insights
Chemotherapy resistance in cancer is often caused by drug efflux pumps. A new real-time PCR assay accurately measures drug-resistance genes, potentially predicting patient response to chemotherapy.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Context:
- Chemotherapy failure is a significant challenge in cancer treatment, frequently stemming from acquired drug resistance.
- Multidrug resistance (MDR), often mediated by P-glycoprotein, and Multidrug Resistance-associated Proteins (MRP) are key mechanisms reducing intracellular drug concentration.
- These resistance mechanisms are particularly relevant in acute leukemia, impacting treatment efficacy.
Purpose:
- To develop and validate a novel quantitative assay for measuring the expression of drug-resistance related genes.
- To specifically target the quantification of MDR-1 and MRP gene expression in clinical samples.
- To establish real-time PCR as a reliable method for assessing chemotherapy resistance markers.
Summary:
- A new quantitative assay utilizing real-time PCR technology has been developed to measure the expression levels of drug-resistance genes, including MDR-1 and MRP.
- The assay was applied to clinical samples, demonstrating its capability to accurately quantify gene expression associated with multidrug resistance.
- Results confirm that real-time PCR is a dependable method for the quantitative determination of drug-resistant gene expression.
Impact:
- The developed real-time PCR assay provides a reliable tool for quantifying drug-resistance gene expression in clinical settings.
- This technique holds the potential to predict patient responsiveness to chemotherapy, enabling personalized treatment strategies.
- Improved prediction of chemotherapy response can lead to more effective cancer treatment regimens and better patient outcomes.